Why the study?
Hypertensive disorders of pregnancy are leading causes of maternal morbidity and mortality in the US, with rates increasing from 1993 to 2017.
Does screening with blood pressure measurements improve outcomes in pregnant persons without a known diagnosis of a hypertensive disorder of pregnancy or chronic hypertension?
Does screening with blood pressure measurements improve outcomes in pregnant persons without a known diagnosis of a hypertensive disorder of pregnancy or chronic hypertension?
The USPSTF recommends routine blood pressure screening throughout pregnancy to prevent maternal morbidity and mortality associated with hypertensive disorders of pregnancy.
Answers are grounded in this paper and cite their sources.
Endorses routine BP screening throughout pregnancy to reduce maternal morbidity; reinforces USPSTF guidelines with moderate-certainty evidence.
Importance: Hypertensive disorders of pregnancy are among the leading causes of maternal morbidity and mortality in the US. The rate of hypertensive disorders of pregnancy has been increasing from approximately 500 cases per 10 000 deliveries in 1993 to 1021 cases per 10 000 deliveries in 2016 to 2017. Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for hypertensive disorders of pregnancy. Population: Pregnant persons without a known diagnosis of a hypertensive disorder of pregnancy or chronic hypertension. Evidence Assessment: The USPSTF concludes with moderate certainty that screening for hypertensive disorders in pregnancy with blood pressure measurements has substantial net benefit. Recommendation: The USPSTF recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy. (B recommendation).
No takes yet. Share an insight, caveat, or question.
Barry et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: